medroxyPROGESTERone (Depo-Provera) IM [Vial ⇒ Vial]
Non - Antineoplastic
Pharmacy: Receiving / Storage / Preparation
Exposure Risk: minimal
• Handling/preparation PPE Requirements: n/a
• Receiving from Distributor: Standard
• Pharmacy Storage Area: Carousel
• Packaging/Reconstitution Location: n/a
• Compounding (Non-Sterile/Sterile) Location: n/a
• Omnicell Load: Yes
Transport
• Transport (dose is placed inside a plastic sealable bag): Standard
Nursing: Storage / Admin.
Exposure Risk: low
• Handling/administration PPE Requirements: Double CX gloves , gown , wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area: Patient Med Drawer, Omnicell
• Signage on Patient Door Required: No
• Manipulation of Dosage Form: n/a
• Special Manipulation for Administration: n/a
Disposal / Spills
• Disposal of Drug Waste: Full- black bin , trace/packaging- yellow bin
• Disposol of Used PPE: yellow bin
• Spill management: Wear CX gloves , items used to clean up spill should be placed in a sealed bag and put in blue bin
Reason for exemption of USP<800> Containment Requirements: Purchased in final dosage form for dispensing, product is drawn up by nursing on unit, proper protections in place for administration
Last updated: Apr. 1, 2022
Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
The following outlines must be followed.
Receiving /
Storage /
Preparation
minimal
Storage /
Admin.
low
Spills